PART 11 GUIDANCE WILL ADDRESS CLINICAL DATA

Devices & Diagnostics Letter
KEYWORDS FDA / Guidances
A A

The FDA is poised to release a new guidance document that addresses the use of computerized systems in clinical trials, a move that could help the agency establish a consistent, risk-based approach to Part 11 for all segments of the pharmaceutical industry.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00